Skip to main content

MONTELUKAST SODIUM

NDC 16571-100 · Rising Pharma Holdings, Inc.

Generic nameMONTELUKAST SODIUM
Dosage formTABLET
RouteORAL
Active ingredient(s)MONTELUKAST SODIUM
Strength10 mg/1
Pharmacologic classLeukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]
Marketing categoryANDA

Packages

16571-100-09 — 90 TABLET in 1 BOTTLE (16571-100-09)

16571-100-10 — 1000 TABLET in 1 BOTTLE (16571-100-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0781-5560 — Montelukast, 0904-6808 — Montelukast Sodium, 13668-079 — Montelukast Sodium, 13668-080 — Montelukast Sodium, 13668-081 — Montelukast Sodium, 13668-531 — Montelukast Sodium, 16729-119 — Montelukast Sodium, 27241-015 — MONTELUKAST SODIUM, 27241-016 — MONTELUKAST SODIUM, 27241-017 — MONTELUKAST, 27241-018 — MONTELUKAST SODIUM, 29300-220 — montelukast sodium, 29300-221 — montelukast sodium, 29300-222 — montelukast sodium, 31722-726 — MONTELUKAST SODIUM, 33342-102 — Montelukast, 42291-622 — Montelukast Sodium, 42291-623 — Montelukast Sodium, 43063-381 — Montelukast Sodium, 43063-762 — Montelukast Sodium, +61 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels